Karuna Therapeutics, Inc. Operating Expenses
Karuna Therapeutics, Inc. reported Operating Expenses of $495.43 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-02-22
- Karuna Therapeutics, Inc. operating expenses for the quarter ending 2023-12-31 was $129.59M, a 43.48% increase year-over-year.
- Karuna Therapeutics, Inc. operating expenses for the quarter ending 2023-09-30 was $136.22M, a 68.01% increase year-over-year.
- Karuna Therapeutics, Inc. operating expenses for the quarter ending 2023-06-30 was $119.91M, a 70.49% increase year-over-year.
- Karuna Therapeutics, Inc. operating expenses for the quarter ending 2023-03-31 was $109.72M, a 87.25% increase year-over-year.
- Karuna Therapeutics, Inc. operating expenses for fiscal 2023 was $495.43M, a 64.97% increase from fiscal 2022.
- Karuna Therapeutics, Inc. operating expenses for fiscal 2022 was $300.31M, a 66.09% increase from fiscal 2021.
- Karuna Therapeutics, Inc. operating expenses for fiscal 2021 was $180.82M, a 151.78% increase from fiscal 2020.
- Karuna Therapeutics, Inc. operating expenses for fiscal 2020 was $71.82M, a 58.17% increase from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2023-12-31 | $129.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $265.80M derived: sum of 2 quarters · filed 2024-02-22 | $385.71M derived: sum of 3 quarters · filed 2024-02-22 | $495.43M 10-K · filed 2024-02-22 |
| 2023-09-30 | $136.22M 10-Q · filed 2023-11-02 | $256.13M derived: sum of 2 quarters · filed 2023-11-02 | $365.85M 10-Q · filed 2023-11-02 | $456.16M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-06-30 | $119.91M 10-Q · filed 2023-08-03 | $229.63M 10-Q · filed 2023-08-03 | $319.94M derived: sum of 3 quarters · filed 2024-02-22 | $401.02M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-03-31 | $109.72M 10-Q · filed 2023-05-04 | $200.03M derived: sum of 2 quarters · filed 2024-02-22 | $281.11M derived: sum of 3 quarters · filed 2024-02-22 | $351.44M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-12-31 | $90.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $171.39M derived: sum of 2 quarters · filed 2024-02-22 | $241.72M derived: sum of 3 quarters · filed 2024-02-22 | $300.31M 10-K · filed 2024-02-22 |
| 2022-09-30 | $81.08M 10-Q · filed 2023-11-02 | $151.41M derived: sum of 2 quarters · filed 2023-11-02 | $210.00M 10-Q · filed 2023-11-02 | $275.15M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $70.33M 10-Q · filed 2023-08-03 | $128.92M 10-Q · filed 2023-08-03 | $194.08M derived: sum of 3 quarters · filed 2024-02-22 | $245.25M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $58.59M 10-Q · filed 2023-05-04 | $123.75M derived: sum of 2 quarters · filed 2024-02-22 | $174.92M derived: sum of 3 quarters · filed 2024-02-22 | $209.45M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $65.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $116.32M derived: sum of 2 quarters · filed 2024-02-22 | $150.85M derived: sum of 3 quarters · filed 2024-02-22 | $180.82M 10-K · filed 2024-02-22 |
| 2021-09-30 | $51.17M 10-Q · filed 2022-11-03 | $85.70M derived: sum of 2 quarters · filed 2022-11-03 | $115.66M 10-Q · filed 2022-11-03 | $140.07M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $34.53M 10-Q · filed 2022-08-08 | $64.49M 10-Q · filed 2022-08-08 | $88.90M derived: sum of 3 quarters · filed 2023-02-23 | $108.43M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $29.96M 10-Q · filed 2022-05-05 | $54.37M derived: sum of 2 quarters · filed 2023-02-23 | $73.90M derived: sum of 3 quarters · filed 2023-02-23 | $91.72M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $24.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $43.94M derived: sum of 2 quarters · filed 2023-02-23 | $61.76M derived: sum of 3 quarters · filed 2023-02-23 | $71.82M 10-K · filed 2023-02-23 |
| 2020-09-30 | $19.53M 10-Q · filed 2021-11-04 | $37.35M derived: sum of 2 quarters · filed 2021-11-04 | $47.41M 10-Q · filed 2021-11-04 | $56.27M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $17.82M 10-Q · filed 2021-08-05 | $27.88M 10-Q · filed 2021-08-05 | $36.75M derived: sum of 3 quarters · filed 2022-02-24 | $46.64M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $10.05M 10-Q · filed 2021-05-06 | $18.92M derived: sum of 2 quarters · filed 2022-02-24 | $28.82M derived: sum of 3 quarters · filed 2022-02-24 | $43.89M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $8.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $18.76M derived: sum of 2 quarters · filed 2022-02-24 | $33.83M derived: sum of 3 quarters · filed 2022-02-24 | $45.41M 10-K · filed 2022-02-24 |
| 2019-09-30 | $9.90M 10-Q · filed 2020-11-05 | $24.97M derived: sum of 2 quarters · filed 2020-11-05 | $36.54M 10-Q · filed 2020-11-05 | $44.69M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $15.07M 10-Q · filed 2020-08-05 | $26.64M 10-Q · filed 2020-08-05 | $34.79M derived: sum of 3 quarters · filed 2021-02-25 | $37.26M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $11.57M 10-Q · filed 2020-05-07 | $19.72M derived: sum of 2 quarters · filed 2021-02-25 | $22.19M derived: sum of 3 quarters · filed 2021-02-25 | $24.62M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $8.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $10.62M derived: sum of 2 quarters · filed 2021-02-25 | $13.05M derived: sum of 3 quarters · filed 2021-02-25 | $14.51M 10-K · filed 2021-02-25 |
| 2018-09-30 | $2.47M 10-Q · filed 2019-11-07 | $4.90M derived: sum of 2 quarters · filed 2019-11-07 | $6.36M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $2.43M 10-Q · filed 2019-08-08 | $3.89M 10-Q · filed 2019-08-08 |